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Background. Additional studies are required to identify risk factors for hepatitis C virus (HCV) transmission
to health care workers after occupational exposure to HCV.
Methods. We conducted a matched case-control study in 5 European countries from 1 January 1991 through
31 December 2002. Case patients were health care workers who experienced seroconversion after percutaneous or
mucocutaneous exposure to HCV. Control subjects were HCV-exposed health care workers who did not experience
seroconversion and were matched with case patients for center and period of exposure.
Results. Sixty case patients and 204 control subjects were included in the study. All case patients were exposed
to HCV-infected fluids through percutaneous injuries. The 37 case patients for whom information was available
were exposed to viremic source patients. As risk factors for HCV infection, multivariate analysis identified needle
placement in a source patient’s vein or artery (odds ratio [OR], 100.1; 95% confidence interval [CI], 7.3–1365.7),
deep injury (OR, 155.2; 95% CI, 7.1–3417.2), and sex of the health care worker (OR for male vs. female, 3.1;
95% CI, 1.0–10.0). Source patient HCV load was not introduced in the multivariate model. In unmatched univariate
analysis, the risk of HCV transmission increased 11-fold for health care workers exposed to source patients with
a viral load 16 log10 copies/mL (95% CI, 1.1–114.1), compared with exposures to source patients with a viral load
4 log10 copies/mL.
Conclusion. In this study, HCV occupational transmission was found to occur after percutaneous exposures.
The risk of HCV transmission after percutaneous exposure increased with deep injuries and procedures involving
hollow-bore needle placement in the source patient’s vein or artery. These results highlight the need for widespread
adoption of needlestick-prevention devices in health care settings, together with other preventive measures.
Infection with hepatitis C virus (HCV) is an important
occupational hazard for health care workers. In lon-
gitudinal studies, attempts have been made to assess
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the risk of infection associated with occupational ex-
posures to HCV in the health care setting. In these
studies, transmission rates ranged from 0% (in 9 of 25
studies) to 10.3% [1–11], with an average rate of 0.5%
[12]. The specific reasons for this substantial variation
in transmission rates and the factors that affect the risk
of HCV infection have not been determined.
There are no approved methods for preventing HCV
infection after exposure. However, the identification of
factors determining an increased risk of HCV trans-
mission would be important for postexposure coun-
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seling and management. For example, there is recent evidence
that an early course of therapy during acute HCV-associated
hepatitis might be associated with a larger proportion of re-
solved infections [13]. Aggressive follow-up schedules based on
HCV RNA testing have therefore been proposed to detect oc-
cupational HCV infection as early as possible for an early course
of therapy [14, 15]. However, routine HCV RNA testing of
every health care worker exposed to an HCV-positive source
would be costly, and its yield would be low [16, 17]. In contrast,
HCV RNA testing of workers subject to occupational exposures
who are at high risk of HCV transmission may be of interest.
To establish which occupational exposures may lead to HCV
transmission and elaborate recommendations for their man-
agement, we conducted an incident case-control study to iden-
tify risk factors for the transmission of HCV to health care
workers after occupational exposure to HCV-infected blood or
body fluids.
PATIENTS AND METHODS
Definitions. Case patients were health care workers with a
documented occupational exposure (i.e., percutaneous or mu-
cocutaneous exposure) to blood or infectious body fluids from
an anti-HCV antibody (anti-HCV)–positive source, with no
other reported concurrent exposure to HCV, who were anti-
HCV negative at the time of exposure, and who had evidence
of HCV seroconversion within 6 months after exposure. Con-
trol subjects were health care workers who had a documented
occupational exposure (i.e., percutaneous or mucocutaneous
exposure) to blood or infectious body fluids from an anti-
HCV–positive source but were anti-HCV negative at the time
of exposure and at least 6 months later. In all of the countries
that participated in this study, serological testing for anti-HCV
was performed using commercial EIAs of the second or third
generation, as available in that country at the time of the ex-
posure. Health care workers who were found to be anti-HCV
positive at baseline or at follow-up underwent confirmation
with recombinant immunoblotting and/or testing of plasma
samples for HCV RNA.
Identification of case patients and control subjects.
Case patients were identified through voluntary reports to na-
tional or regional systems for surveillance of occupational in-
fections in France, Italy, Spain, Switzerland, and the United
Kingdom during the 12-year period from 1 January 1991
through 31 December 2002. At each health care center reporting
a case, physicians in charge of occupational health were re-
quired to identify 4 control subjects in the center’s data set.
Control subjects were matched to case patients by the center
in which the case had been exposed and by the period of
exposure (i.e., the control subject’s exposure was required to
be within 1 year of the corresponding case patient’s exposure).
In some centers, 14 case patients were identified with exposures
that had occurred within 1 year of the corresponding case
patient’s exposure. In this situation, among all eligible control
subjects, 4 control subjects having the closest exposure date to
the case’s exposure date were asked to be enrolled. Assuming
an exposure rate of 30% among control subjects (as was re-
ported for exposure to a needle placed in the source patient’s
artery or vein in a study of nurses in France [18]), a 2-tailed
significance level of 5%, and a power level of 90%, the en-
rollment of 49 case patients and 196 control subjects was ex-
pected to permit detection of a minimal OR of 3 [19].
Data collection. For each case patient and control subject,
demographic information and information concerning the
characteristics of the exposure and of the source patient were
collected with use of a standardized questionnaire translated
into the language of each participating country. In each country,
the questionnaires were filled in by a national investigator who
had reviewed the incident reports that had been completed at
the time of exposure. Because information for the source pa-
tient was not always available or known to the case patient or
control patient at the time of exposure, it was obtained ret-
rospectively by reviewing the medical records of the source
patients.
Information about health care workers included age and sex.
Information about exposure included the type of exposure (i.e.,
percutaneous injury or mucous membrane or skin contami-
nation with infectious body fluid) and the body fluid to which
the health care worker had been exposed (i.e., blood or other
body fluids). For percutaneous injuries, information was col-
lected about the device involved, the use of gloves, and the
severity of the injury. Procedures involving a needle placed in
the source patient’s artery or vein (e.g., phlebotomy, insertion
of an intravenous catheter, or collection of arterial blood gas)
were distinguished from other procedures, such as injection
into an intravenous catheter. The severity of injury was defined
as superficial (surface scratch), moderate (penetration of the
skin and bleeding), or deep (deep puncture or wound with
bleeding). Information about the source patient included HCV
RNA status (i.e., HCV RNA detection and HCV load), as well
as hepatitis B virus and HIV status. Cut off values for HCV
titer categories were determined using the distribution of HCV
load in control subjects (HCV load 33rd and 66th percentiles).
Statistical analysis. MacNemar’s x2 test and the Wilcoxon
rank sum test for paired data were used to compare the un-
matched general characteristics of case patients and control
subjects. The crude disease “exposure” association was deter-
mined by estimating the OR and its 95% CI. This was done
by univariate conditional logistic regression, to account for the
matched design. OR significance was assessed by the Wald test
[20].
When the P values for variables concerning demographic
information, the type of exposure, and source patients were
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Figure 1. Distribution of cases of hepatitis C virus (HCV) transmission to health care workers by year of exposure to infectious blood or body
fluids of HCV antibody–positive source patients and by country, 1991–2002.
!.25 in univariate analysis, they were submitted to a multivar-
iate conditional logistic regression model [21]. Information
concerning source patients’ HCV RNA level was not introduced
in this model because of the large proportion of missing data
for this variable, which were seldom collected at the time of
exposure. Backward stepwise regression procedures were used
to identify the final multivariate model, and possible interac-
tions were examined [21]. The goodness-of-fit of the model
was assessed by using the logistic regression diagnostics pro-
cedure [22].
P values !.05 (2-tailed) were to be statistically considered
significant. Statistical analyses were performed with SAS soft-
ware, version 8.2 (SAS Institute).
RESULTS
The study population included 60 case patients (35 from
France, 16 from Italy, 4 from Spain, 3 from the United King-
dom, and 2 from Switzerland) and 204 control subjects (110
from France, 64 from Italy, 12 from Spain, 9 from the United
Kingdom, and 9 from Switzerland). The ratio of control sub-
jects to case patients was less than 4:1, because in some centers,
!4 control subjects were identified within 1 year of correspond-
ing case’s exposure. The distribution of case patients per year
of exposure to HCV indicated an annual increase in the number
reported between 1991 (when HCV antibody testing became
available) and 1995, followed by a decrease during the period
1996–1997, and stability from 1998 through 2002 (figure 1).
In this study, all case patients were exposed to body fluids
through percutaneous exposures (table 1). Of these exposures,
57 (95%) involved hollow-bore needles, and 3 (5%) involved
solid needles or sharps. Fifty-nine case patients (98.3%) were
exposed to blood, and 1 case patient was exposed to ascitic
fluid. In contrast, 171 (83.8%) of 204 control subjects were
exposed to body fluids through percutaneous exposure, and 32
(15.7%) were exposed through mucocutaneous exposures. One
hundred ninety control subjects (93.1%) were exposed to
blood, and 12 were exposed to other body fluids.
Compared with the control subjects, the case patients were
older (median age, 38 years vs. 35 years; ), and morePp .03
of them were male (30.0% vs. 18.6; ). By univariatePp .04
analysis, HCV infection was associated with injuries by hollow-
bore needles (occurring in 95% of case patients, compared with
60.3% of control subjects; ), procedures involving nee-P ! .0001
dle placement in the source patient’s vein or artery (occurring
in 80.0% of case patients, compared with 38.2% of control
subjects; ), and deep injuries (occurring in 56.6% ofP ! .0001
case patients, compared with 16.2% of control subjects; P !
) (table 1). There was no difference between case patients.0001
and control subjects regarding the use of gloves or the hepatitis
B virus and HIV status of the source patient.
All 37 (100.0%) of the case patients for whom data on HCV
RNA level were available were exposed to viremic source pa-
tients (i.e. source patients in whom HCV RNA was detected),
compared with 42 (85%) of the 61 corresponding control sub-
jects. Data on HCV load were available for 12 case patients and
27 control subjects. In unmatched univariate analysis, the risk
of HCV transmission was found to be 11 times higher (95%
CI, 1.1–114.1; ) for health care workers who were ex-Pp .04
posed to source patients with an HCV load 16 log10 copies/mL
and 5.5 times higher (95% CI, 0.6–55.5; ) for thosePp .15
exposed to source patients with a viral load of 4–6 log10 copies/
mL than it was for health care workers exposed to source pa-
tients with an HCV load !4 log10 copies/mL (table 1).
In multivariate analysis, HCV transmission remained sig-
nificantly associated with procedures involving hollow-bore
needle placement in the source patient’s vein or artery, the
severity of injury, and the sex of the health care worker (table
2). Interaction terms were not included in this model, because
they were not statistically significant on inclusion in the final
model. The logistic regression diagnostics procedure showed
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Table 1. Analysis of risk factors for hepatitis C virus (HCV) seroconversion in health care
workers who did (case patients) or did not (matched control subjects) experience HCV sero-
conversion after occupational exposure to HCV.
Variable
Case patients
(n p 60)
Matched
control subjects
(n p 204)
Unadjusted
matched OR
(95% CI) P
Type of exposure
Percutaneous 60 (100) 171 (83.8)
Body fluid contact with mucous
membranes or skin 0 (0) 32 (15.7)
Body fluid involved in exposure
Blood 59 (98.3) 190 (93.1) 4.5 (0.5–43.5) .20
Other body fluid 1 (1.7) 12 (5.9) 1.0
Device involved in exposurea
Suture needle 1 (1.7) 21 (10.3) 1.4 (0.1–25.3) .80
Hollow-bore needle
Not in vein or artery 9 (15.0) 45 (22.1) 5.1 (0.6–42.2) .13
In vein or artery 48 (80.0) 78 (38.2) 20.3 (2.5–162.9) .005
Other 2 (3.3) 27 (13.2) 1.0
Severity of injurya
Superficial 3 (5.0) 61 (29.9) 1.0
Moderate 21 (35.0) 65 (31.7) 15.8 (2.1–122.5) .008
Deep 34 (56.6) 34 (16.2) 57.6 (7.2–457.9) .0001
Use of gloves
Yes 32 (53.3) 111 (54.4) 1.0
No 20 (33.3) 73 (35.8) 0.9 (0.5–1.9) .843
Sex
Female 41 (68.3) 156 (76.5) 1.0
Male 18 (30.0) 38 (18.6) 2.2 (1.0–4.6) .04
Age, median years (range) 38 (22–57) 35 (19–63) 1.0 (1.0–1.1) .03
Source patient
HIV status
Negative 42 (70.0) 122 (59.8) 1.0
Positive 12 (20.0) 41 (20.0) 0.9 (0.4–2.1) .80
Hepatitis B virus status
Negative 43 (71.6) 133 (65.2) 1.0
Positive 6 (10.0) 14 (6.9) 2.1 (0.6–7.0) .24
HCV loadb
4 log10 copies/mL 1 (1.7) 11 (5.4) 1.0
14 to 6 log10 copies/mL 5 (8.3) 10 (4.9) 5.5 (0.6–55.5) .15
16 log10 copies/mL 6 (10.0) 6 (2.9) 11.0 (1.1–114.1) .04
NOTE. Data are no. (%) of subjects, unless otherwise indicated. Data for case patients and control subjects
may not total 60 and 204, respectively, because of missing data.
a Analysis restricted to percutaneous exposures.
b The matched design of the study was not considered in this analysis because of the large amount of missing
data.
that the entire set of covariate patterns was correctly fitted by
the final model.
DISCUSSION
In this study, conducted in 5 European countries from 1991
through 2002, occupational HCV transmission to health care
workers was only found to occur after percutaneous exposure
to viremic blood or body fluids. In a multivariate conditional
logistic regression model, in which the source patient’s HCV
load was not introduced, the risk of HCV transmission to a
health care worker after percutaneous exposure increased for
deep injuries and procedures involving hollow-bore needle
placement in the source patient’s vein or artery. Health care
worker sex was also found to be independently associated with
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Table 2. Multivariate conditional logistic regression analysis
of risk factors for hepatitis C virus (HCV) transmission to health
care workers after percutaneous exposure to HCV-infected body
fluids.
Variable
Adjusted
matched OR
(95% CI) P
Device involved in exposure
Suture needle or other sharp object 1.0
Hollow-bore needle
Not in vein or artery 10.6 (0.9– 128.4) .063
In vein or artery 100.1 (7.3–1365.7 .0005
Severity of injury
Superficial 1.0
Moderate 47.7 (2.3- 974.1) .01
Deep 155.2 (7.1–3417.2) .001
Sex of health care worker
Female 1.0
Male 3.1 (1.0–10.0) .056
HCV transmission, with an increased risk of transmission for
men. In univariate analysis of data from a subset of case patients
and control subjects, the risk of HCV transmission increased
with the titer of HCV in the source patient, although we had
to break the matched design of the study for this analysis be-
cause of the small numbers.
No data on factors that affect occupational HCV transmis-
sion to health care workers exist. To identify these factors, the
present analysis assembled a database involving 60 case patients
with documented occupational exposure to infectious body flu-
ids from an HCV-positive source and evidence of HCV sero-
conversion in temporal association with the exposure. This
represents a large data set in an area where data are scarce. We
conducted an incident-matched case-control study and per-
formed a multivariate conditional logistic regression analysis
to identify independent risk factors for HCV transmission.
Our findings should nevertheless be interpreted with caution.
Primarily, this study was a retrospective review of surveillance
data obtained from different sources. Its retrospective design
may have introduced bias in the estimation of the nature of
exposures through either recall bias or misclassification. How-
ever, erroneous estimation of the nature of exposures related
to recall bias is unlikely, because the data for most variables
were collected through objective documentations derived from
incident reports completed at the time of exposure. The only
variables collected retrospectively were source patient’s HCV
RNA level and HBV and HIV status, which are objective var-
iables that are less prone to recall bias. Misclassification bias
may have affected some data, particularly subjective variables,
such as the severity of injury. However, errors in determining
these variables were probably not dependent on the case-control
status of the health care workers, because the incident reports
were completed before those who drafted them knew whether
the health care worker was a case patient or a control subject.
Moreover, for both case patients and their matched control
subjects, information about exposure was usually obtained by
the same occupational health physician because of the matched
design of the study; this physician probably tended to classify
exposures in a self-consistent fashion. More importantly, the
retrospective design of the study (and the fact that HCV RNA
quantification for viremia was introduced on a widespread basis
in Europe after 1995–1996 [23–25]) resulted in a high pro-
portion of missing data when HCV RNA information con-
cerning source patients was collected. Nevertheless, even with
a small number of observations, we were able to show an as-
sociation between HCV RNA titer and HCV transmission, but
the matched design of the study was not applied to this analysis.
In addition, because of the high proportion of missing values,
we were not able to use the source patient HCV RNA status
data in our final multivariate model. As a result, in this study,
the effect of independent risk factors for HCV transmission
was not adjusted to the HCV RNA status of the source patients.
In this study, occupational HCV transmission to health care
workers was only found to occur after percutaneous exposures
(not after mucocutaneous exposures). However, it is important
to emphasize the fact that, although the largest proportion of
HCV transmission to health care workers in our study occurred
through percutaneous injuries, case reports have documented
transmission of HCV as a result of splashes of blood from
infected patients onto health care workers’ mucous membranes
[26–28]. Consequently, one should not reject mucocutaneous
exposures as a potential source of HCV transmission. Moreover,
the promotion of barrier protections, such as consistent use of
appropriate eyewear (e.g., sealed protective goggles) that could
prevent occupational infection from conjunctival exposure to
bloodborne pathogens, should not be stopped in light of the
results of our study.
The increased risk of occupational blood-borne pathogen
transmission with deep injuries and after procedures involving
hollow-bore needles has already been reported for HIV by
Cardo et al. [29] in a case-control study involving health care
workers who were occupationally exposed to HIV-infected
blood. Our results for HCV transmission confirm that these
factors probably represent indirect measures of inoculum vol-
ume. In injuries caused by hollow-bore needles, a larger volume
of blood is transferred, and in procedures involving needle
placement in the source patient’s vein or artery, the needle
contains undiluted blood.
The finding that HCV transmission only occurs after ex-
posure to viremic patients is consistent with previous reports
[30]. In a systematic review by Dore and colleagues of 29 studies
(including studies of vertical transmission, transmission after
transplantation, transfusion of blood components, and need-
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lestick exposure), no case of HCV transmission was identified
among subjects exposed to HCV RNA–negative sources [30].
Moreover, in our study, we found that the risk of transmission
increased with the HCV RNA titer. This finding has already
been reported for other transmission models, such as mother-
to-infant transmission [31, 32], but has not been reported for
occupational transmissions. However, this finding needs to be
confirmed, first, because it was based on the small number of
case patients and control subjects for whom the HCV RNA
titer in the source patient was available, and second, because
it was obtained by unmatched univariate analysis.
We observed an unexpected association between health care
worker sex and HCV transmission. In several previous cohort
studies, male sex was identified as an independent risk factor
for HCV infection after adjustment, in particular, for trans-
fusion history [33–35]. In addition, some studies found that
male sex was associated with an increased risk of HCV infection
during hemodialysis [36, 37], although this was not confirmed
by others [38–40]. Nevertheless, we cannot rule out the pos-
sibility that the assessment of risk was affected by unidentified
confounding variables or selection bias. Additional epidemio-
logical and laboratory studies are therefore needed to confirm
that the risk of HCV transmission is greater in men.
We did not find an association between the HIV status of
the source patient and HCV transmission. Although anecdotal
reports and surveillance studies of exposed health care work-
ers—as well as the results of studies of vertical transmission—
suggest that the frequency of HCV transmission increases when
the source patient is coinfected with HIV [41–46], other studies
found conflicting results [6, 47, 48]. The interaction between
these viruses is poorly understood. Additional studies are there-
fore needed to investigate the impact of HIV status on HCV
transmission.
Differences between the systems for the surveillance of oc-
cupational infections within different countries (e.g., national
vs. regional surveillance systems) resulted in differences be-
tween the number of case patients reported by the countries
participating in the present study. Nevertheless, we observed
an increase in the number of case patients with occupational
HCV transmission reported annually from 1991 through 1995,
followed by a decrease in 1996 and 1997 and a stable number
since 1998. Although this result should be interpreted with
caution because of the possible reporting bias, the overall in-
crease observed from 1991 through 1995 was probably due to
an improvement in occupational HCV infection surveillance
systems. Regarding the overall decrease observed in 1996 and
after, a similar decrease in the risk of percutaneous injury
among health care workers, especially nurses, has been docu-
mented in France [18] (which country contributed about 60%
of the case patients). This decrease was probably due to better
compliance with universal, standard precautions and to the
introduction of needlestick-prevention devices on a wider scale,
as demonstrated by several studies [49–51].
The results of the present study—and especially the identi-
fication of a higher risk of occupational transmission after per-
cutaneous injuries with hollow-bore and blood-filled needles—
highlight the need for widespread adoption of needlestick-pre-
vention devices in health care settings (i.e., safety-engineered
needle devices, such as intravenous catheters and blood-draw-
ing devices), together with other preventive measures, such as
education, to reduce the risk of occupational infection for
health care workers. In addition, until new anti-HCV drugs
(such as HCV serine protease inhibitors, which may eventually
be used for postexposure prophylaxis) become available [52],
the present results have important implications for the coun-
seling and follow-up of health care workers after exposure. They
suggest that, after occupational exposure to HCV, assessment
of the risk of transmission should take into account the severity
of the injury, the device involved, and the HCV RNA status of
the source patient. Following this assessment, health care work-
ers at low risk for transmission should be fully informed of
this fact, because such information would, no doubt, substan-
tially reduce the anxiety caused by their injury. Follow-up
schedules based on the results of anti-HCV antibody testing
could then be proposed to health care workers who are at low
risk. For health care workers experiencing high-risk exposures,
follow-up schedules based on alanine transaminase monitoring,
as currently recommended by European guidelines [17, 53], or
HCV RNA testing may be proposed; if acute HCV infection is
detected, adequate treatments may be initiated, although the
ideal timing and regimen of antiviral therapy remain to be
defined. However, these follow-up strategies and the frequency
of postexposure testing need to be further investigated through
well-designed cost-effectiveness studies.
Acknowledgments
We are indebted to physicians in charge of occupational health in France,
Italy, Spain, Switzerland, and the United Kingdom for collecting infor-
mation from exposed health care workers, as well as to the health care
workers themselves for their assistance in providing this information
Financial support. French Agence National de Recherches sur le SIDA
(ANRS 1286) and the Italian Ministry of Health-Istituto Superiore di Sanita`,
Istituto Superiore per la Prevenzione e la Sicurezza del Lavoro and Ricerca
Corrente Istituti di Ricovero e Cura a Carattere Scientifico.
Potential conflicts of interest. All authors: no conflicts.
References
1. Lanphear BP, Linnemann CC Jr, Cannon CG, DeRonde MM, Pendy
L, Kerley LM. Hepatitis C virus infection in healthcare workers: risk
of exposure and infection. Infect Control Hosp Epidemiol 1994; 15:
745–50.
2. Zuckerman J, Clewley G, Griffiths P, Cockcroft A. Prevalence of hep-
atitis C antibodies in clinical health care workers. Lancet 1994; 343:
1618–20.
3. Arai Y, Noda K, Enomoto N, et al. A prospective study of hepatitis C
virus infection after needlestick accidents. Liver 1996; 16:331–4.
Occupational HCV Transmission Risk Factors • CID 2005:41 (15 November) • 1429
4. Takagi H, Uehara M, Kakizaki S, et al. Accidental transmission of HCV
and treatment with interferon. J Gastroenterol Hepatol 1998; 13:
238–43.
5. Hasan F, Askar H, Al Khalidi J, Al Shamali M, Al Kalaoui M, Al Nakib
B. Lack of transmission of hepatitis C virus following needlestick ac-
cidents. Hepatogastroenterology 1999; 46:1678–81.
6. De Carli G, Puro V, Ippolito G. Risk of hepatitis C virus transmission
following percutaneous exposure in healthcare workers. Infection
2003; 31:22–7.
7. Petrosillo N, Puro V, Ippolito G. Prevalence of hepatitis C antibodies
in health care workers. Italian Study Group on Blood-borne Occu-
pational Risk in Dialysis. Lancet 1994; 344:339–40.
8. Hernandez ME, Bruguera M, Puyuelo T, Barrera JM, Sanchez Tapias
JM, Rodes J. Risk of needle-stick injuries in the transmission of hepatitis
C virus in hospital personnel. J Hepatol 1992; 16:56–8.
9. Mitsui T, Iwano K, Masuko K, et al. Hepatitis C virus infection in
medical personnel after needlestick accident. Hepatology 1992; 16:
1109–14.
10. Sodeyama T, Kiyosawa K, Urushihara A, et al. Detection of hepatitis
C virus markers and hepatitis C virus genomic-RNA after needlestick
accidents. Arch Intern Med 1993; 153:1565–72.
11. Baldo V, Floreani A, Dal Vecchio L, et al. Occupational risk of blood-
borne viruses in healthcare workers: a 5-year surveillance program.
Infect Control Hosp Epidemiol 2002; 23:325–7.
12. Jagger J, Puro V, De Carli G. Occupational transmission of hepatitis
C virus. JAMA 2002; 288:1469.
13. Jaeckel E, Cornberg M, Wedemeyer H, et al. Treatment of acute hep-
atitis C with interferon alfa-2b. N Engl J Med 2001; 345:1452–7.
14. Garcia JM, Serrano PL, Terron Sdel C, et al. Very rapid evolution of
infection with hepatitis C virus transmitted by an accidental needles-
tick. Clin Infect Dis 2003; 36:1632–4.
15. Updated US Public Health Service Guidelines for the management of
occupational exposures to HBV, HCV, and HIV and recommendations
for postexposure prophylaxis. MMWR Recomm Rep 2001; 50:1–52.
16. Torres M, Campins M, Esteban JI, Costa J, Bastida MT, Bruguera M.
Is it useful to perform the RNA test for hepatitis C in health care
workers after an accidental needlestick? J Hepatol 2000; 33:686.
17. De Carli G, Puro V, Scognamiglio P, Ippolito G. Infection with hepatitis
C virus transmitted by accidental needlesticks. Clin Infect Dis 2003;
37:1718–9.
18. Abiteboul D, Lamontagne F, Lolom I, Tarantola A, Descamps J, Bouvet
E. Incidence des accidents exposant au sang chez le personnel infirmier
en France me´tropolitaine, 1999–2000 : re´sultats d’une enqueˆte multi
centrique dans 32 hoˆpitaux. Bulletin d’Epide´miologie Hebdomadaire
2002; 51:256–9.
19. Schesselman J. Sample size. In: Schesselman J, Stolley P, eds. Case-
control studies design, conduct, analysis. Oxford: Oxford University
Press, 1982:144–70.
20. Schesselman J. Basic methods of analysis. In: Schesselman J, Stolley P,
eds. Case-control studies design, conduct, analysis. Oxford: Oxford
University Press, 1982:171–226.
21. Hosmer D, Lemshow S. The multiple logistic regression model. In:
Hosmer D, Lemshow S, eds. Applied logistic regression. New York:
John Wiley and Sons, 1989:25–37.
22. Collett D. Modelling binary data. 2nd ed. Boca Raton, FL : Chapman
and Hall/CRC, 2003.
23. Seme K, Poljak M. Use of a commercial PCR kit for detection of
hepatitis C virus. Eur J Clin Microbiol Infect Dis 1995; 14:549–52.
24. Nolte FS, Thurmond C, Fried MW. Preclinical evaluation of AMPLI-
COR hepatitis C virus test for detection of hepatitis C virus RNA. J
Clin Microbiol 1995; 33:1775–8.
25. Roth WK, Lee JH, Ruster B, Zeuzem S. Comparison of two quantitative
hepatitis C virus reverse transcriptase PCR assays. J Clin Microbiol
1996; 34:261–4.
26. Hosoglu S, Celen M, Akalin S, Geyik M, Soyoral Y, Kara I. Transmission
of hepatitis C by blood splash into conjunctiva in a nurse. Am J Infect
Control 2003; 31:502–4.
27. Ippolito G, Puro V, Petrosillo N, De Carli G, Micheloni G, Magliano
E. Simultaneous infection with HIV and hepatitis C virus following
occupational conjunctival blood exposure. JAMA 1998; 280:28.
28. Sartori M, La Terra G, Aglietta M, Manzin A, Navino C, Verzetti G.
Transmission of hepatitis C via blood splash into conjunctiva. Scand
J Infect Dis 1993; 25:270–1.
29. Cardo DM, Culver DH, Ciesielski CA, et al. A case-control study of
HIV seroconversion in health care workers after percutaneous expo-
sure. Centers for Disease Control and Prevention Needlestick Sur-
veillance Group. N Engl J Med 1997; 337:1485–90.
30. Dore GJ, Kaldor JM, McCaughan GW. Systematic review of role of
polymerase chain reaction in defining infectiousness among people
infected with hepatitis C virus. Brit Med J 1997; 315:333–7.
31. Okamoto M, Nagata I, Murakami J, et al. Prospective reevaluation of
risk factors in mother-to-child transmission of hepatitis C virus: high
virus load, vaginal delivery, and negative anti-NS4 antibody. J Infect
Dis 2000; 182:1511–4.
32. Lin HH, Kao JH, Hsu HY, et al. Possible role of high-titer maternal
viremia in perinatal transmission of hepatitis C virus. J Infect Dis
1994; 169:638–41.
33. Habib M, Mohamed MK, Abdel-Aziz F, et al. Hepatitis C virus infection
in a community in the Nile Delta: risk factors for seropositivity. He-
patology 2001; 33:248–53.
34. Murphy E, Bryzman S, Williams A, et al. Demographic determinants
of hepatitis C virus seroprevalence among blood donors. JAMA
1996; 275:995–1000.
35. Patino-Sarcinelli F, Hyman J, Camacho LA, Linhares DB, Azevedo JG.
Prevalence and risk factors for hepatitis C antibodies in volunteer blood
donors in Brazil. Transfusion 1994; 34:138–41.
36. Dentico P, Buongiorno R, Volpe A, et al. Prevalence and incidence of
hepatitis C virus (HCV) in hemodialysis patients: study of risk factors.
Clin Nephrol 1992; 38:49–52.
37. Sivapalasingam S, Malak SF, Sullivan JF, Lorch J, Sepkowitz KA. High
prevalence of hepatitis C infection among patients receiving hemo-
dialysis at an urban dialysis center. Infect Control Hosp Epidemiol
2002; 23:319–24.
38. Schneeberger PM, Keur I, van Loon AM, et al. The prevalence and
incidence of hepatitis C virus infections among dialysis patients in the
Netherlands: a nationwide prospective study. J Infect Dis 2000; 182:
1291–9.
39. Sandhu J, Preiksaitis JK, Campbell PM, Carriere KC, Hessel PA. Hep-
atitis C prevalence and risk factors in the northern Alberta dialysis
population. Am J Epidemiol 1999; 150:58–66.
40. Hinrichsen H, Leimenstoll G, Stegen G, Schrader H, Folsch UR,
Schmidt WE. Prevalence and risk factors of hepatitis C virus infection
in haemodialysis patients: a multicentre study in 2796 patients. Gut
2002; 51:429–33.
41. Garces JM, Yazbeck H, Pi-Sunyer T, Gutierrez-Cebollada J, Lopez-
Colomes JL. Simultaneous human immunodeficiency virus and hep-
atitis C infection following a needlestick injury. Eur J Clin Microbiol
Infect Dis 1996; 15:92–4.
42. Ridzon R, Gallagher K, Ciesielski C, et al. Simultaneous transmission
of human immunodeficiency virus and hepatitis C virus from a needle-
stick injury. N Engl J Med 1997; 336:919–22.
43. Sulkowski MS, Ray SC, Thomas DL. Needlestick transmission of hep-
atitis C. JAMA 2002; 287:2406–13.
44. Tovo PA, Palomba E, Ferraris G, et al. Increased risk of maternal-infant
hepatitis C virus transmission for women coinfected with human im-
munodeficiency virus type 1. Italian Study Group for HCV Infection
in Children. Clin Infect Dis 1997; 25:1121–4.
45. Zanetti AR, Tanzi E, Paccagnini S, et al. Mother-to-infant transmission
of hepatitis C virus. Lombardy Study Group on Vertical HCV Trans-
mission. Lancet 1995; 345:289–91.
46. Serra C, Torres M, Campins M. Occupational risk of hepatitis C virus
infection after accidental exposure. Catalan Group for the Study of the
Occupational Risk of HCV infection in hospitals. J Hepatol 1997; 27:
1139.
1430 • CID 2005:41 (15 November) • Yazdanpanah et al.
47. Resti M, Azzari C, Galli L, et al. Maternal drug use is a preeminent
risk factor for mother-to-child hepatitis C virus transmission: results
from a multicenter study of 1372 mother-infant pairs. J Infect Dis
2002; 185:567–72.
48. Armstrong GL, Perz JF, Alter MJ. Perinatal hepatitis C virus trans-
mission: role of human immunodeficiency virus infection and injection
drug use. J Infect Dis 2003; 187:872.
49. Tarantola A, Gollot F, Astagneau P, Bru¨cker G, Bouvet E. Re´sultats de
la surveillance des accidents exposant au sang 1995–1998 des AES sur
le re´seau CCLIN Paris-Nord. Bulletin CCLIN Paris-Nord 2001; 19:2–3.
50. Dale JC, Pruett SK, Maker MD. Accidental needlesticks in the phle-
botomy service of the Department of Laboratory Medicine and Pa-
thology at Mayo Clinic Rochester. Mayo Clin Proc 1998; 73:611–5.
51. Gershon RR, Pearse L, Grimes M, Flanagan PA, Vlahov D. The impact
of multifocused interventions on sharps injury rates at an acute-care
hospital. Infect Control Hosp Epidemiol 1999; 20:806–11.
52. Hinrichsen H, Benhamou Y, Wedemeyer H, et al. Short-term antiviral
efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in
hepatitis C genotype 1 patients. Gastroenterology 2004; 127:1347–55.
53. European Group for the Standardization of the Management of Oc-
cupational Exposure to HIV/Blood-Borne Infections and Evaluation
of Post-Exposure Prophylaxis in Europe. European recommendations
for the management of health care workers occupationally exposed to
hepatitis B virus and hepatitis C virus: final report to the European
Commission, Directorate-General Health Care and Consumer Protec-
tion, Unit F4. Project number SI2 .322294. November 2002. Available
at: http://europa.eu.int/comm/health/ph_projects/2000/com_diseases/
fp_commdis_2000_frep_10_en.pdf. Accessed 9 November 2004
